211 related articles for article (PubMed ID: 25308005)
1. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.
Lazaris AC; Tseleni-Balafouta S; Papathomas T; Brousalis T; Thomopoulou G; Agrogiannis G; Patsouris ES
Eur J Endocrinol; 2006 Jun; 154(6):827-33. PubMed ID: 16728542
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of growth factors HGF (Hepatocyte Growth Factor), TGFbeta1 (transforming growth factor beta1) and IGF-I (Insulin Like Growth Factor I) in parathyroid tumors.
Astl J; Veselý D; Matucha P; Martínek J; Kucera T; Lastuvka P; Betka J; Sterzl I
Neuro Endocrinol Lett; 2004 Oct; 25(5):356-60. PubMed ID: 15580170
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
5. A unique use of intraoperative digital specimen radiography in the treatment of primary hyperparathyroidism.
Saguan N; Recabaren J
Am Surg; 2013 Oct; 79(10):1098-101. PubMed ID: 24160807
[TBL] [Abstract][Full Text] [Related]
6. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
Mazeh H; Chen H; Leverson G; Sippel RS
Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
[TBL] [Abstract][Full Text] [Related]
7. Role of growth factors on human parathyroid adenoma cell proliferation.
Cavallaro G; Cucina A; Coluccia P; Petramala L; Cotesta D; Polistena A; Zinnamosca L; Letizia C; Rosato L; Cavallaro A; De Toma G
World J Surg; 2010 Jan; 34(1):48-54. PubMed ID: 20020293
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in primary hyperparathyroidism.
Segiet OA; Michalski M; Brzozowa-Zasada M; Piecuch A; Żaba M; Helewski K; Gabriel A; Wojnicz R
Ann Diagn Pathol; 2015 Apr; 19(2):91-8. PubMed ID: 25648902
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
Garcia de la Torre N; Buley I; Wass JA; Jackson DG; Turner HE
J Clin Endocrinol Metab; 2004 Jun; 89(6):2890-6. PubMed ID: 15181073
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of hyperparathyroidism].
Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
[TBL] [Abstract][Full Text] [Related]
12. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
13. [Morphology of the parathyroid glands. A study of 146 samples and review of the literature].
Pino Rivero V; Pantoja Hernández CG; Mora Santos ME; González Palomino A; Pardo Romero G; Gómez de Tejada Romero R; Blasco Huelva A
An Otorrinolaringol Ibero Am; 2007; 34(2):135-42. PubMed ID: 17549960
[TBL] [Abstract][Full Text] [Related]
14. The tiny parathyroid adenoma.
Liechty RD; Teter A; Suba EJ
Surgery; 1986 Dec; 100(6):1048-52. PubMed ID: 3787460
[TBL] [Abstract][Full Text] [Related]
15. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
17. Preoperative localization of enlarged parathyroid glands.
Mäkäräinen H; Lähde S; Kairaluoma MI; Leinonen A
Ann Clin Res; 1984; 16 Suppl 40():51-4. PubMed ID: 6732171
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 proliferative index in parathyroid adenoma & hyperplasia.
Karak AK; Sarkar C; Chumber S; Tandon N
Indian J Med Res; 1997 May; 105():235-8. PubMed ID: 9183080
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal/polyclonal PAX-8, PTH and GATA3 immunohistochemistry in parathyroid lesions.
Altınay S; Erözgür B; Dural AC; Volante M; Papotti MG
J Endocrinol Invest; 2021 Sep; 44(9):1997-2008. PubMed ID: 33566340
[TBL] [Abstract][Full Text] [Related]
20. P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids.
Ricci F; Mingazzini PL; Sebastiani V; D'Erasmo E; Letizia C; De Toma G; Alò PL
Ann Diagn Pathol; 2002 Aug; 6(4):229-35. PubMed ID: 12170454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
